Dabigatran versus Warfarin in Patients with Atrial Fibrillation
0
Authors
Stuart Connolly
Stuart Connolly•Paul Reilly•Lars Wallentin
Published
August 31, 2009
Abstract
Warfarin reduces the risk of stroke in patients with atrial fibrillation but increases the risk of hemorrhage and is difficult to use. Dabigatran is a new oral direct thrombin inhibitor.
